Avast takes $113m equity injection

Anti-virus maker wins big.

Anti-virus software maker Avast has received a US$100 million ($113 million) equity injection after Summit Partners took a minority stake in the firm.

Avast made a popular free anti-virus program with upgrades to premium paid versions.

The company claimed it protected "one out of every five computers around the world from malware".

It had no plans to change its distribution model, although it conceded it hadn't foreseen in the early days the level of demand it would eventually receive for its product.

"When we first launched free distribution of Avast anti-virus in the early 2000s, we gave ourselves room to grow - but never dreamed that the product would gain such global popularity," co-founder Eduard Kucera said.

Copyright © iTnews.com.au . All rights reserved.
Avast takes $113m equity injection

What are your thoughts on this article? Add your comment below.

To begin commenting right away, you can log in below or register an account if you don't yet have one. Please read our guidelines on commenting. Offending posts will be removed and your access may be suspended. Abusive or obscene language will not be tolerated. The comments below do not necessarily reflect the views or opinions of SC Magazine, Haymarket Media or its employees.

NOTE: You must be a registered member of SC Magazine to post a comment.

Click here to login | Click here to register
comments powered by Disqus
Sign up to receive SC Magazine email newsletters
   FOLLOW US...
Most Read